Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT05088733
Eligibility Criteria:
Inclusion Criteria:
* Meet the criteria of hepatocellular carcinoma
* Patients who tested positive for hepatitis B surface antigen (HBsAg) for \>6 months
* Meet the criteria of anemia
* Ages Eligible for Study: ≤75 years old;
* Informed consent from the patient.
Exclusion Criteria:
* Patients with upper gastrointestinal bleeding within 3 months before enrollment;
* History of blood transfusion within 3 months before enrollment;
* Patient with other chronic hepatopathy, such as AIH, NAFLD, ALD;
* Serious problem of heart, lung, or kidney with severe dysfunction;
* Pregnant or child breast feeding women;
* Mental or cognitive disorders;
* Participating in other drug trials;
* Who are allergic to the study drug.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05088733
Study Brief:
Protocol Section:
NCT05088733